{
  "primary": "CASP7",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "Caspase-7 was identified as a novel interactor of ATXN3 by co-immunoprecipitation from mass spectrometry data.",
  "functions": [
    {
      "function": "Proteolytic Cleavage of ATXN3",
      "arrow": "activates",
      "cellular_process": "During apoptosis, initiator caspases activate executioner caspases like Caspase-7. Activated caspases then cleave a multitude of cellular substrates, including ATXN3. This proteolytic event generates smaller, C-terminal fragments of ATXN3 that contain the polyglutamine tract.",
      "effect_description": "Caspase-mediated cleavage of polyQ-expanded ATXN3 is a pathological event that generates toxic protein fragments. These fragments have a higher propensity to misfold and aggregate than the full-length protein, thereby exacerbating neurotoxicity in Spinocerebellar Ataxia Type 3.",
      "biological_consequence": [
        "Apoptotic signaling → Caspase cascade activation → Caspase-7 (and other caspases) cleave mutant ATXN3 → Generation of aggregation-prone C-terminal fragments → Enhanced formation of toxic aggregates → Increased neurotoxicity and cell death"
      ],
      "specific_effects": [
        "ATXN3 is cleaved by caspases during apoptosis, a process that is inhibited by broad-spectrum caspase inhibitors.",
        "Caspase cleavage generates toxic, aggregation-prone fragments containing the polyQ tract.",
        "While multiple caspases can cleave ATXN3, the specific role of Caspase-7 has been more directly demonstrated for cleaving Ataxin-7, another polyglutamine disease protein, suggesting a conserved mechanism.",
        "Preventing caspase cleavage of ATXN3 mitigates neurodegeneration in animal models of SCA3."
      ],
      "evidence": [
        {
          "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
          "journal": "Neurobiology of Disease",
          "year": 2004,
          "relevant_quote": "Finally, caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis.",
          "pmid": "15140190"
        },
        {
          "paper_title": "A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration",
          "journal": "Journal of Neuroscience",
          "year": 2004,
          "relevant_quote": "The proteolytic fragment is proposed to be a product of caspase enzymes. [...] Truncated mutant ataxin-3 aggregates and recruits the full-length disease protein in transfected cells.",
          "pmid": "15537899"
        }
      ],
      "pathway": {
        "name": "Apoptosis",
        "canonical_name": "Apoptosis",
        "ontology_id": "GO:0006915",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "15140190",
        "15537899"
      ],
      "interaction_effect": "activation",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "binds",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input incorrectly describes the interaction as ATXN3 activating CASP7. The correct mechanism is the opposite: activated caspases, including potentially Caspase-7, act upon ATXN3 by cleaving it. This is a catabolic event, not an activation by ATXN3.",
  "mechanism": "During apoptosis, initiator caspases activate executioner caspases like Caspase-7. Activated caspases then cleave a multitude of cellular substrates, including ATXN3. This proteolytic event generates smaller, C-terminal fragments of ATXN3 that contain the polyglutamine tract.",
  "effect": "Caspase-mediated cleavage of polyQ-expanded ATXN3 is a pathological event that generates toxic protein fragments. These fragments have a higher propensity to misfold and aggregate than the full-length protein, thereby exacerbating neurotoxicity in Spinocerebellar Ataxia Type 3.",
  "summary": "ATXN3 inhibits CASP7 to modulate proteolytic cleavage of atxn3, ultimately affecting increased neurotoxicity and cell death.",
  "evidence": [
    {
      "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
      "journal": "Neurobiology of Disease",
      "year": 2004,
      "relevant_quote": "Finally, caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis."
    },
    {
      "paper_title": "A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration",
      "journal": "Journal of Neuroscience",
      "year": 2004,
      "relevant_quote": "The proteolytic fragment is proposed to be a product of caspase enzymes. [...] Truncated mutant ataxin-3 aggregates and recruits the full-length disease protein in transfected cells."
    }
  ],
  "pathways": [
    {
      "name": "Apoptosis",
      "canonical_name": "Apoptosis",
      "ontology_id": "GO:0006915",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "binding",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--binds-- CASP7:",
  "protein_a": "ATXN3",
  "protein_b": "CASP7",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-07T22:39:21.533246Z",
  "last_updated": "2025-12-07T22:39:21.533246Z"
}